Zhejiang Hisoar Pharmaceutical Co., Ltd.
Символ: 002099.SZ
SHZ
6.34
CNYПазарна цена днес
-63.7547
Съотношение P/E
-0.3671
Коефициент PEG
10.20B
MRK Cap
- 0.01%
Доходност на DIV
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099-SZ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 6911.26 | 1490.8 | 1837.4 | 1969.7 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 337.76 | 390.7 | 9.5 | -10.1 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 2164.35 | 625.6 | 627.3 | 489.1 | ||||||||||||||||||||
balance-sheet.row.inventory | 3400.72 | 1102.4 | 908 | 727.4 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 119.1 | 26.8 | 64.3 | 53.6 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 12595.43 | 3245.7 | 3436.9 | 3239.9 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 12047.97 | 3097.5 | 2981.2 | 2561.6 | ||||||||||||||||||||
balance-sheet.row.goodwill | 2628.64 | 711 | 757.7 | 757.7 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 2122.94 | 555.8 | 490.1 | 517.9 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 4751.57 | 1266.8 | 1247.9 | 1275.6 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 2071.46 | 728.7 | 249.9 | 58 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 199.33 | 52.3 | 52.2 | 42.2 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 1381.61 | 2.1 | 51.8 | 1.4 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 19769.56 | 5147.4 | 4583 | 3938.7 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 32364.99 | 8393.1 | 8019.9 | 7178.6 | ||||||||||||||||||||
balance-sheet.row.account-payables | 2842.37 | 995 | 1028.8 | 613.2 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 5022.52 | 838.3 | 574.4 | 430.4 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 96.95 | 23.5 | 37.7 | 43.7 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 174.74 | 162.1 | 17.8 | 22 | ||||||||||||||||||||
Deferred Revenue Non Current | 237.33 | 54.4 | 53.4 | 48.3 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 283.94 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 287.36 | 129.2 | 1.2 | 1.4 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 704.02 | 317.5 | 173.6 | 144.7 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 44.74 | 14 | 17.8 | 22 | ||||||||||||||||||||
balance-sheet.row.total-liab | 9199.99 | 2288.2 | 1906.3 | 1326.5 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 6474.86 | 1618.7 | 1618.7 | 1618.7 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | 4143.54 | 1329.6 | 1410.8 | 1362.9 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 3427.74 | 268.1 | 344.2 | 279.5 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 9136.45 | 2891.6 | 2741.3 | 2591 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 23182.59 | 6108 | 6115 | 5852.1 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 32364.99 | 8393.1 | 8019.9 | 7178.6 | ||||||||||||||||||||
balance-sheet.row.minority-interest | -17.6 | -3.1 | -1.4 | 0 | ||||||||||||||||||||
balance-sheet.row.total-equity | 23165 | 6104.9 | 6113.6 | 5852.1 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 32364.99 | - | - | - | ||||||||||||||||||||
Total Investments | 2714.33 | 720.9 | 259.4 | 47.9 | ||||||||||||||||||||
balance-sheet.row.total-debt | 5197.26 | 1000.5 | 592.2 | 430.4 | ||||||||||||||||||||
balance-sheet.row.net-debt | -1714 | -490.4 | -1235.7 | -1539.3 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -80.69 | 86.1 | 93.9 | 319.7 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | -94.32 | 336.5 | 294.2 | 256.6 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -1.6 | -3.1 | 48.7 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 62.6 | 200.4 | 37.6 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -377.5 | -350.2 | -142 | ||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -229.8 | -755 | -353.2 | ||||||||||||||||||||
cash-flows.row.inventory | 0 | -213.7 | -194.1 | 102.1 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | 67.6 | 602 | 60.3 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -1.6 | -3.1 | 48.7 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 262.9 | 9.9 | -132.9 | 13.4 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 87.89 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -142.94 | -179.4 | -229.6 | -74.2 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 5.44 | 5.9 | 0.2 | 3.7 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | -42 | -464.1 | -251.5 | -0.1 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -48.5 | 5 | 2.5 | -3.7 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | -44.69 | 12.3 | -30.6 | 3.7 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -268.65 | -620.3 | -509 | -70.6 | ||||||||||||||||||||
cash-flows.row.debt-repayment | -1745.14 | -1817 | -929 | -230 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 236.9 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | -236.9 | ||||||||||||||||||||
cash-flows.row.dividends-paid | -122.19 | -195.4 | -53.4 | -478.1 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 969.88 | 1890.6 | 1063.2 | 696.9 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -267.65 | -121.9 | 80.8 | -11.2 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 16.55 | 75.1 | -25.5 | -38.5 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -410.17 | -551 | -351.4 | 413.6 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 5960 | 1037 | 1588 | 1939.4 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 6370.17 | 1588 | 1939.4 | 1525.8 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 87.89 | 116.1 | 102.4 | 533.9 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -142.94 | -179.4 | -229.6 | -74.2 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | -55.05 | -63.3 | -127.2 | 459.7 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 2066.3 | 2704.1 | 2484.8 | 2471.4 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 1722.26 | 1983.9 | 1559.4 | 1348.8 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 344.05 | 720.3 | 925.4 | 1122.6 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 114.53 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 95.81 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 29.72 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | -32.96 | 295.5 | 477.5 | 389.5 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 462.57 | 570 | 770.6 | 658.4 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 2184.82 | 2553.9 | 2330 | 2007.2 | ||||||||||||||||||||
income-statement-row.row.interest-income | 58.01 | 33.5 | 33 | 30.9 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 43 | 36.5 | 21.9 | 11.4 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 29.72 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -0.93 | -139.6 | 1 | -1.8 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -32.96 | 295.5 | 477.5 | 389.5 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -0.93 | -139.6 | 1 | -1.8 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 43 | 36.5 | 21.9 | 11.4 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 403.28 | 336.5 | 333 | 280.4 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | -76.25 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | -479.53 | 240.4 | 122 | 395.3 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | -480.46 | 100.8 | 123 | 393.5 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | -49.13 | 14.7 | 29.2 | 73.8 | ||||||||||||||||||||
income-statement-row.row.net-income | -429.56 | 88 | 95.2 | 319.7 |
Често задавани въпроси
Какво е Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) общи активи?
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) общите активи са 8393099770.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 1023720461.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.027.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.027.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.069.
Какъв е общият приход на предприятието?
Общият приход е -0.074.
Каква е Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 88013729.000.
Какъв е общият дълг на фирмата?
Общият дълг е 1000453916.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 570013794.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 1596168996.000.